Augmented Reality Based 3D Modelling for Sentinel Lymph Node Localization in Cutaneous Melanoma: A Pilot Study
Journal of Surgical Oncology · 2026
DOI: 10.1002/jso.70282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2026. Verfasst von Qais Adawi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery, Surgical Oncology Unit, Sheba Medical Center, Affiliated with Tel Aviv University, Ramat-Gan, Israel. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Sentinel Lymph Node, Sentinel Lymph Node Biopsy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Sentinel lymph node biopsy (SLNB) is standard for staging high‐risk melanoma, but current mapping provides limited spatial guidance. This pilot study assessed whether augmented reality (AR) projected 3D models can improve sentinel node localization compared with the gamma probe.
Methods
In this prospective study, 10 melanoma patients undergoing SLNB at Sheba Medical Center had preoperative sentinel lymphoscintigraphy using SPECT/CT imaging segmented to generate patient‐specific 3D models. Models were projected onto the patient via an AR headset before incision. Localization accuracy was measured as the deviation (mm) between AR3D‐identified and gamma probe–identified sentinel lymph node positions.
Results
Ten patients were enrolled in this pilot study. The median age was 71 years (range 30–77). Primary tumor sites included upper limb ( n = 5), trunk ( n = 3), Lower Limb ( n = 1), and Head and Neck ( n = 1). The median Breslow thickness was 1.1 mm (range 0.8–24 mm), with ulceration in 2 cases. Model generation was successful in all patients, with each model projected onto the patient using the AR headset and evaluated by the surgeon prior to incision. The median deviation between AR3D model and the gamma probe localization was 12 mm (range 0–40 mm), with 43% of cases ≤ 10 mm. No AR‐related complications occurred.
Conclusions
AR‐based 3D modelling was feasible and safe for SLNB localization in melanoma. Although accuracy varied, in nearly half of the cases, AR3D model was within 10 mm of the gamma probe detection. These preliminary results supported further refinement of the technique and evaluation in larger, multicenter trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Surgery, Surgical Oncology Unit, Sheba Medical Center, Affiliated with Tel Aviv University, Ramat-Gan, Israel.
- The Surgical Innovation Laboratory, ARC Innovation Center, Sheba Medical Center, Ramat-Gan, Israel.
- Ella Lemelbaum Institute of Immuno-Oncology and Melanoma, Sheba Medical Center, Ramat-Gan, Israel.
- Department of Nuclear Medicine, Sheba Medical Center, Ramat Gan, Israel.
ORCID-Profile: Eyal Mor
Zitieren
APA
Adawi, Q., Meiri, H., Yoschpe, A., Shapira, R., Grynberg, S., Schachter, J., Eshet, Y., Eifer, M., Nachmany, I., Zippel, D., & Mor, E. (2026). Augmented Reality Based 3D Modelling for Sentinel Lymph Node Localization in Cutaneous Melanoma: A Pilot Study. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70282
Vancouver
Adawi Q, Meiri H, Yoschpe A, Shapira R, Grynberg S, Schachter J, et al. Augmented Reality Based 3D Modelling for Sentinel Lymph Node Localization in Cutaneous Melanoma: A Pilot Study. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70282
BibTeX
@article{Adawi2026,
author = {Adawi, Qais and Meiri, Hila and Yoschpe, Assaf and Shapira, Ronnie and Grynberg, Shirly and Schachter, Jacob and Eshet, Yael and Eifer, Michal and Nachmany, Ido and Zippel, Douglas and Mor, Eyal},
title = {Augmented Reality Based 3D Modelling for Sentinel Lymph Node Localization in Cutaneous Melanoma: A Pilot Study},
journal = {Journal of Surgical Oncology},
year = {2026},
doi = {10.1002/jso.70282}
}
EUVIMED